The efficacy and safety of direct renin inhibitor aliskiren on the blood glucose control of DPP-IV inhibitor
Phase of Trial: Phase IV
Latest Information Update: 14 May 2016
At a glance
- Drugs Aliskiren (Primary) ; Amlodipine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Jul 2012 Status changed from not yet recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 21 Jul 2012 Actual initiation date (1 Feb 2011) added as reported by University Hospital Medical Information Network - Japan.
- 09 Feb 2011 New trial record